GLP-1s caloric deficit depletes it faster than your body replenishes it
In some cases, switching to an alternative GLP-1 receptor agonist with a different pharmacokinetic profile may be considered
While the drugs appear to be safe the most common side effects are nausea, diarrhea, vomiting, constipation, and stomach pain theyve only been on the market for a few years and caution is still needed, said Mitchell Lazar, founding director of the Institute for Diabetes, Obesity and Metabolism at the University of Pennsylvania Perelman School of Medicine
They represent a potential change in how obesity care is delivered
It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use
Sermorelins approximate half-life is thought to be between 11 and 12 minutes